Advent Pharma Ltd.

ADVENT

BD0492ADVPL9

Pharmaceuticals

End-of-day quote Dhaka S.E. Other stock markets 23:00:00 26/06/2024 BST			5-day change	1st Jan Change
25.9 ^BDT	0.00%		-0.77%	+4.02%

04-29	Advent Pharma Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI
02-06	Advent Pharma Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI

Advent Pharma Ltd. Recommends Cash Dividend for the Year Ended on June 30, 2021

October 31, 2021 at 03:24 pm

The Board of Directors of Advent Pharma Ltd. has recommended 2% Cash dividend for the year ended on June 30, 2021.

Latest news about Advent Pharma Ltd.

Advent Pharma Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	04-28	CI
Advent Pharma Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	02-06	CI
Advent Pharma Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2023	11-13	CI
Advent Pharma Ltd. Recommends Cash Dividend for the Year Ended June 30, 2023	29/10/23	CI
Advent Pharma Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	15/05/23	CI
Advent Pharma Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	13/02/23	CI
Advent Pharma Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2022	24/11/22	CI
Advent Pharma Ltd. Completes Signing Agreement of Distributorship with Alltech Biotechnology Pvt Ltd	17/11/22	CI
Advent Pharma Ltd. Recommends Cash Dividend for the Year Ended June 30, 2022	30/10/22	CI
Advent Pharma Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	24/05/22	CI
Advent Pharma Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021	30/01/22	CI
Advent Pharma Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2021	02/12/21	CI
Advent Pharma Ltd. Recommends Cash Dividend for the Year Ended on June 30, 2021	31/10/21	CI
Advent Pharma Ltd. Appoints Asif Iqbal Chowdhury as Chairman	06/05/21	CI
21,567,500 Ordinary Shares of Advent Pharma Limited are subject to a Lock-Up Agreement Ending on 12-APR-2021.	11/04/21	CI
Advent Pharma Ltd. Appoints Faria Binte Alam as the Managing Director	02/07/20	CI
Advent Pharma Ltd. Announces Approval to Introduce New Products	24/03/20	CI
Advent Pharma Ltd. Announces Approval to Introduce New Products	04/02/20	CI
Advent Pharma Ltd. Reports Earnings Results for the Second Quarter Ended December 31, 2019	29/01/20	CI
Advent Pharma Limited Reports Earnings Results for the First Quarter Ended September 30, 2019	29/10/19	CI
Advent Pharma Limited Reports Earnings Results for the Third Quarter Ended March 31, 2019	28/04/19	CI
27,032,500 Ordinary Shares of Advent Pharma Limited are subject to a Lock-Up Agreement Ending on 12-APR-2019.	11/04/19	CI
Advent Pharma Limited Announces Change of Head Office	02/04/19	CI
Advent Pharma Limited Reports Earnings Results for the Second Quarter Ended December 31, 2018	29/01/19	CI
Advent Pharma Limited Recommends Cash Dividend for the Year Ended June 30, 2018	21/10/18	CI

Advent Pharma Limited is a Bangladesh-based pharmaceutical company. The Company is engaged in manufacturing, importing and marketing of animal health care drugs, nutritional supplements and feed additives for livestock like powder, bolus and liquid dosage forms. Its product category includes aquaculture, cattle, and poultry. Its aquaculture products include GRO-PLUS, Oxi-D Bolus, and RUMIGEST HP. Its cattle products include ABC Solution, ACIPURE PLUS, AD-HISTA Vet Injection, ADBOVI Powder, ADCAL-P, ADCET BOLUS, ADCIPCIN, ADCIPCINE BOLUS, ADLYTE, ADPROLIM PLUS POWDER and ADRIZOL Bolus. Its poultry products include ADSULPH Bolus, ADVIT B COMPLEX, ADVIT C, ADVIT CP, ADVIT CP PLUS Bolus, ADVIT DB Powder, ADVIT E-SEL, ADVIT-D PLUS Solution, ADVOMICA, ADZURIL, ADZYL Bolus, ADZYME LIQUID, ADZYME POWDER, COUGH OFF, EGG BOOST, FERON VET, Liver On, MASTIVIT, NEO SUPER VET, NEPHROSOL, TOXOSORB, TILFOS VET, NUTARIN, and others.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Veterinary Drugs

	1st Jan change	Capi.
ADVENT PHARMA LTD.	+4.02%	20.5M
ELANCO ANIMAL HEALTH INCORPORATED	-4.23%	7.05B
BLUESTAR ADISSEO COMPANY	+20.62%	3.56B
VIRBAC	-8.48%	3B
VIMIAN GROUP AB	+16.39%	1.71B
VETOQUINOL SA	-7.71%	1.21B
JINYU BIO-TECHNOLOGY CO., LTD.	-32.96%	1.11B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.	-36.59%	1.06B
WUHAN KEQIAN BIOLOGY CO.,LTD	-27.53%	944M
SWEDENCARE AB	-2.56%	885M